US FDA approves Regeneron's ultra-rare blood disease drug
(Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its drug to treat a rare blood disease. The
2023-08-19 02:24
A large health insurer is trying a new way to lower drug costs for millions of members
A major California health insurer is shaking up the prescription drug pricing system as it seeks to lower the cost of medication for its 4.8 million members.
2023-08-17 23:49
US Supreme Court to scrutinize Purdue Pharma bankruptcy settlement
By John Kruzel and Andrew Chung WASHINGTON (Reuters) -The U.S. Supreme Court on Thursday agreed to hear a challenge by
2023-08-11 04:17
Supreme Court blocks $6 billion Purdue Pharma opioid settlement and will hear case this fall
The Supreme Court on Thursday blocked Purdue Pharma from going forward with bankruptcy proceedings, which the Biden administration has called an "unprecedented" arrangement that would ultimately offer the Sackler family broad protection from opioid-related civil claims.
2023-08-11 03:56
Purdue asks Supreme Court not to block opioid settlement during US appeal
By Dietrich Knauth NEW YORK Oxycontin maker Purdue Pharma on Friday asked the U.S. Supreme Court to reject
2023-08-05 06:26
Teva agrees to pay $126 million to US hospitals over opioids
By Brendan Pierson Teva Pharmaceutical Industries Ltd has agreed to pay up to $126 million to U.S. hospitals
2023-08-04 00:53
CVS is laying off 5,000 workers
CVS is laying off about 5,000 employees in a cost-cutting effort, the pharmacy chain confirmed Tuesday.
2023-08-01 20:48
US asks Supreme Court to delay Purdue Pharma bankruptcy settlement
By Dietrich Knauth NEW YORK The U.S. Department of Justice on Friday asked the U.S. Supreme Court to
2023-07-29 05:54
Japan's Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine
TOKYO (Reuters) -Japan's Takeda Pharmaceutical posted first-quarter profit that beat analysts' estimates, citing solid sales of mainstay drugs and the
2023-07-27 16:16
Purdue Pharma bankruptcy can proceed despite potential US Supreme Court appeal
By Dietrich Knauth NEW YORK OxyContin maker Purdue Pharma may proceed with a bankruptcy settlement that protects its
2023-07-26 05:54
Nvidia invests $50 million in Recursion to train AI models for drug discovery
(Reuters) -Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which
2023-07-12 20:52
US FDA approves BioMarin's gene therapy for hemophilia A
By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's gene therapy for hemophilia A,
2023-06-30 04:28